Does EVEROLIMUS Cause Infusion site induration? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Infusion site induration have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.1% of all adverse event reports for EVEROLIMUS.
22
Reports of Infusion site induration with EVEROLIMUS
0.1%
of all EVEROLIMUS reports
0
Deaths
0
Hospitalizations
How Dangerous Is Infusion site induration From EVEROLIMUS?
Of the 22 reports.
Is Infusion site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Infusion site induration?
TREPROSTINIL (598)
HUMAN IMMUNOGLOBULIN G (209)
FOSCARBIDOPA\FOSLEVODOPA (112)
AMBRISENTAN (49)
MACITENTAN (26)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (25)
CAPECITABINE (23)
ZOLEDRONIC ACID (22)
PAMIDRONATE (20)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (17)
Which EVEROLIMUS Alternatives Have Lower Infusion site induration Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE